Tag:

Express Scripts

Latest Headlines

Latest Headlines

Angered by Walgreens deal, Express Scripts blocks access to Valeant's Glumetza

PBM giant Express Scripts has long been a leader in the fight to tamp down drug prices, and now, it's using its formulary power to freeze out a diabetes drug from controversial Valeant.

More formulary exclusions are on their way as smaller PBMs get in on the action

PBM giants Express Scripts and CVS Health have so far found formulary exclusions an effective way to manage drug costs. And unfortunately for pharma companies, that tactic is catching on.

Express Scripts backs Imprimis' $1-per-pill rival to Turing's pricey Daraprim

Turing Pharmaceuticals may be offering discounts on its now-pricey toxoplasmosis drug Daraprim--50% discounts, for hospitals--but Express Scripts is backing another, far cheaper alternative. It's the compounded duo drug recently unveiled by Imprimis at $1 per pill.

Express Scripts rolls out value-based pricing for cancer meds

Express Scripts will put its money behind a new value-based reimbursement model next year, using comparative data and indication-specific pricing to favor "clinically superior" meds. The pharmacy benefits manager will roll out the approach in cancer first, with anti-inflammatory meds close behind.

Express Scripts cuts off Horizon-linked pharmacy in widening crackdown

Earlier this month, in the wake of Valeant's canceled relationship with controversial specialty pharmacy Philidor, Express Scripts said it would take a hard look at other specialty pharmacies that deal mostly with a single drugmaker. And now, it's cutting off one that works closely with Ireland's Horizon Pharmaceuticals.

Express Scripts looks into pharmacies at AbbVie, Teva in wake of Valeant's Philidor saga

Valeant may be through with specialty pharmacy Philidor, which CVS;and Express Scripts dropped from their networks last week on questions about its business practices. But other companies still maintain relationships with specialty pharmacies, and Express Scripts now says it's reviewing those, too.

Express Scripts: AbbVie hep C meds still available for the right patients

A new FDA warning about AbbVie's hepatitis C cocktail hasn't affected patients' access to treatment, pharmacy benefits manager Express Scripts said on Wednesday.

AbbVie faces the music with Express Scripts over FDA's Viekira Pak warning

Last week, the FDA came down on AbbVie for serious liver issues tied to its hep C fighters Viekira Pak and Technivie, calling on the company to update the drugs' labels to warn doctors against using the meds in patients with advanced forms of the disease. Now the Illinois pharma could be facing the music with Express Scripts, as the PBM is planning to hold a meeting to review the news and changes to the drugs' labels.

Discounts make room for both Sanofi, Amgen's PCSK9 meds on Express Scripts' top formulary

At Express Scripts, both Sanofi and Regeneron's Praluent and Amgen's Repatha scored a spot on the preferred formulary, which gives both PCSK9 products a chance to snare the pharmacy benefits manager's patients.

Two's company for PCSK9 meds as Praluent, Repatha both nab coverage from top PBM

At Express Scripts, both Sanofi and Regeneron's Praluent and Amgen's Repatha scored a spot on the preferred formulary, which gives both PCSK9 products a chance to snare the pharmacy benefits manager's patients.